Loading...
XNAS
CRON
Market cap1.05bUSD
Jul 09, Last price  
2.78USD
1D
1.09%
1Q
7.75%
Jan 2017
152.09%
IPO
1,584.85%
Name

Cronos Group Inc

Chart & Performance

D1W1MN
XNAS:CRON chart
P/E
P/S
6.96
EPS
Div Yield, %
Shrs. gr., 5y
1.85%
Rev. gr., 5y
26.13%
Revenues
149m
+26.81%
00-665,0003,405,000412,3223,956,37612,121,00017,837,64146,719,00064,561,00086,749,00087,241,000117,615,000149,153,083
Net income
-10m
L
-30,657-26,929-4,151,000278,279-885,0002,527,422-21,636,000876,114,329-73,137,000-396,107,000-168,734,000-73,963,00041,080,000-9,612,374
CFO
26m
+39.67%
-119,290-1,432,435-992,645-4,817,802-4,411,928-7,150,356-97,642,871-144,871,000-153,616,000-88,948,000-42,835,00018,843,00026,318,798

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
IPO date
May 07, 2014
Employees
447
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT